LEBEL FRANCOIS (Chief Medical Officer) sold 0.6% of their position (2.15K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $7.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/6/2021ACC: 0001209191-21-025722
Officer· Chief Medical Officer
Since Jun 2019
-2.15K
Net shares
Net seller
$7.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.15K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Direct
Shares
−1.13K
Price / share
$3.31
Trade value
$3.73K
% of position
0.3%
4/5/2021
353.02K→351.89K
Common Stock, $0.001 par value
Direct
Shares
−1.02K
Price / share
$3.24
Trade value
$3.32K
% of position
0.3%
4/6/2021
351.89K→350.87K
Total
Net shares
−2.15K
Net value
-$7.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 4/5/2021 | S · Sale | −1.13K | $3.31 | $3.73K | 0.3% | 353.02K | 351.89K |
| Common Stock, $0.001 par value Direct | 4/6/2021 | S · Sale | −1.02K | $3.24 | $3.32K | 0.3% | 351.89K | 350.87K |
| Total | −2.15K | -$7.05K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned7.23K
Total
7.23K indirect7.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.23K | Indirect |
| Total | 7.23K | 7.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported